Drugs / hMSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03186417 | Dec 2017 → Apr 2023 | rheumatoid arthritis | MetroHealth Medical Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hMSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03186417 ↗ |
| Modality | Cell therapy | “allogeneic mesenchymal stem cells (MSCs)” NCT03186417 ↗ |